SEC Form 4 · accession 0001140361-15-042494
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorge Saucedo
Director
Period of report
Nov 19, 2015
Accepted (ET)
Nov 20, 2015 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 19, 2015 | S | 7,715 | $33.45 | D | 19,320 | D | |
| Common Stock | holding | — | — | — | 27,035 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $6.39 | holding | — | — | — | — | Apr 21, 2019 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F2 | $9.61 | holding | — | — | — | — | Apr 22, 2020 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F2 | $11.72 | holding | — | — | — | — | Apr 22, 2021 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F2 | $11.63 | holding | — | — | — | — | May 4, 2022 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $33.40 to $33.50 per share. Dr. Saucedo has provided to the Company, and upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
- F2100% fully vested.